Argentina reported 317 adverse cases in those vaccinated with Sputnik V

The Ministry of Health announced this Friday (01.01.2021) that 317 adverse events have been reported after the application of 32,013 doses of Sputnik V vaccine, in the first two days of the national vaccination campaign against covid-19 that Argentina began last Tuesday.

These adverse events are what have been notified until 23:59 local time on December 30 passed to the Integrated Health Information System of Argentina (SIISA), according to the first vaccine safety surveillance report published today by the Ministry of Health.

"44.2% of the ESAVIs (adverse events) reported correspond to people with fever, headache and / or myalgia started 6 to 8 hours after vaccination," he explained.

These events are related to the Sputnik V vaccine, added the report, which details that within the expected reactions, the following may occur: injection site pain, hyperemia, swelling.

And that within systemic reactions, the following may occur: flu-like syndrome short-lived onset within 24 to 48 hours (characterized by chills, fever, arthralgia, myalgia, asthenia, malaise, headache) or less frequent gastrointestinal symptoms (nausea, dyspepsia, decreased appetite).

"These reactions have an average duration of 24 hours," he explained.

Argentina began the simultaneous vaccination process throughout the country last Tuesday, with the batch of 300,000 doses of the Russian vaccine Sputnik V received on Thursday of the previous week, which applies to healthcare personnel.